Carregant...
(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482633/ https://ncbi.nlm.nih.gov/pubmed/28415595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16418 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|